Diabetologia

, Volume 52, Issue 12, pp 2585–2589

Heritability and genetic correlations of insulin resistance and component phenotypes in Asian Indian families using a multivariate analysis

Short Communication

DOI: 10.1007/s00125-009-1504-7

Cite this article as:
Zabaneh, D., Chambers, J.C., Elliott, P. et al. Diabetologia (2009) 52: 2585. doi:10.1007/s00125-009-1504-7

Abstract

Aims/hypothesis

Insulin resistance and related metabolic disturbances are more common among Asian Indians than European whites. Little is known about the heritability of insulin resistance traits in Asian Indians. Our objective was to estimate heritabilities and genetic correlations in Asian Indian families.

Methods

Phenotypic data were assembled for 181 UK Asian Indian probands with premature CHD, and their 1,454 first-, second- and third-degree relatives. We calculated (narrow-sense) heritabilities and genetic correlations for insulin resistance traits, and common environmental effects using all study participants and a multivariate model. The analysis was repeated in a subsample consisting of individuals not on drug therapy.

Results

Heritability estimates (SE) for individuals not on drug therapy were: BMI 0.31 (0.04), WHR 0.27 (0.04), systolic BP 0.29 (0.03), triacylglycerol 0.40 (0.04), HDL-cholesterol 0.53 (0.04), glucose 0.37 (0.03), HOMA of insulin resistance (HOMA-IR) 0.22 (0.04), and HbA1c 0.60 (0.04). We observed many significant genetic correlations between the traits, in particular between HOMA-IR and BMI. Heritability estimates were lower for all phenotypes when analysed among all participants.

Conclusions/interpretation

Genetic factors contribute to a significant proportion of the total variance in insulin resistance and related metabolic disturbances in Asian Indian CHD families.

Keywords

Asian Indian Genetic correlations Heritability Insulin resistance Multivariate analysis Shared environment 

Abbreviations

DBP

Diastolic BP

HOMA-IR

HOMA of insulin resistance

IR

Insulin resistance

SBP

Systolic BP

TG

Triacylglycerol

Introduction

Insulin resistance (IR), type 2 diabetes and associated disorders of dyslipidaemia, hypertension, coagulation abnormalities and atherosclerosis [1] are major causes of morbidity and mortality, and are rapidly increasing globally [2]. Asian Indians (people from India, Pakistan, Bangladesh or Sri Lanka) have a high prevalence of IR and related metabolic disturbances compared with other populations. Among Asian Indians, IR and associated metabolic phenotypes are reported to account for up to 70% of the excess CHD risk, compared with European whites. The contribution of genetic factors underlying IR and its related metabolic disturbances amongst Asian Indians has not been extensively investigated. We therefore estimated the heritabilities and genetic correlations of IR and its component phenotypes using a multivariate model, in a large, well-characterised set of extended families of Asian Indian CHD patients.

Methods

Study population

We identified 181 Asian Indian men and women with premature CHD, defined as myocardial infarction, coronary revascularisation or coronary artery stenosis ≥70% in one or more major epicardial vessel before the age of 60 years. All had been living in the UK for an average of 26 years (range 1–55 years), and originated predominantly from the Punjab state, India. Some were born overseas and some in the UK: 19% born in Africa, 44% born in India, 35% born in the UK and 2% born in other countries. Recruitment was through Ealing and Hammersmith hospitals. We invited all available first-, second- and third-degree and spouse relatives of the 181 probands for phenotypic characterisation. In total 1,663 people were investigated, including the probands. From these individuals, 29 were excluded as having white European-descent ethnicity; this comprised any individual and his/her offspring. The remaining 1,634 individuals from 180 families were 86% Sikh and 14% Hindu, a comparison between the two groups is in Electronic supplementary material (ESM) Table 1.

Clinical measurements

Data were collected by trained nurses according to a standard protocol. Participants attended after an 8 h fast. Physical assessment included BP and anthropometric measurements (height, weight and waist and hip circumference), from which BMI (a measure of general adiposity) and WHR (a measure of central adiposity) were calculated. Fasting glucose, insulin, total and HDL-cholesterol and triacylglycerol (TG) were measured, and HOMA of insulin resistance (HOMA-IR) derived using fasting insulin and glucose concentrations [3]. Type 2 diabetes was defined as a physician diagnosis of diabetes, or blood glucose ≥7.0 mmol/l and hypertension as a physician diagnosis of hypertension on treatment, or BP ≥140/90 mmHg. The study was approved by the Local Research Ethics Committee, and consent was obtained from all participants.

Statistical analysis

Fasting glucose, HDL-cholesterol, TG and HOMA-IR were log transformed (loge) to improve normality. All traits were adjusted for age and sex, and adjusted phenotypic values >4 SD below or above the mean were excluded. For heritability and genetic correlation estimation, the age- and sex-adjusted residuals were analysed using VCE version 6, which provides heritability estimates under an additive genetic model [4]. Religion (Hindu or Sikh) was included as a covariate. VCE (variance component estimation, originally developed for agricultural data), uses multivariate analysis, incorporating partial correlations between the traits; this provides improved estimates of heritability compared with univariate and bivariate methods. Details of the multivariate models used in VCE are in the ESM methods.

Variance components were estimated incorporating all eight traits: systolic BP (SBP), BMI, WHR, loge glucose, loge HDL-cholesterol, loge TG, HbA1c and loge HOMA-IR simultaneously in a linear mixed model. We could not include both BP traits (SBP and diastolic BP [DBP]) in the model because of a high genetic correlation between them (rA = 96%; data not shown), which causes computational problems. We decided to include SBP. The model in univariate form is given by \( y = Xb + a + c + e \), where y is a vector of observed trait values, and a, c and e are vectors of random effects: additive genetic (a), common environment (c) and residual (e). The term Xb represents fixed covariate effects. The correlation structure of a is given by kinships derived from each pedigree. Mother was used as a proxy for the common environment, i.e. individuals with the same mother are assumed to have shared the same early childhood environment [5]. The residual effects e are assumed to be uncorrelated.

Heritability (h2) is the proportion of phenotypic variation in a population that is attributable to additive genetic variation, calculated as the ratio of the genetic variance under an additive model (VA) to the total phenotypic variance (VP) [6]. The common environmental effect (c2) is the proportion of phenotypic variance that is attributable to shared environment within a family, calculated as the ratio of the within-family common environment component (VC) to VP. Genetic correlations (rA) and common environmental correlations (rC) are measures of the extent to which the resemblance between relatives can be attributed to shared genetic or environmental factors, respectively.

To minimise potential bias in measured phenotypes introduced by treatments effects, our first analysis excluded observations for individuals on treatment affecting the phenotype. Observations for glucose, HOMA-IR and HbA1c were excluded for individuals on type 2 diabetes treatment; observations for SBP, HDL-cholesterol and TG were excluded for individuals on CHD treatment; observations for SBP were excluded for treatment for hypertension; and HDL-cholesterol and TG observations were excluded for individuals on lipid-lowering medication. Data were separately analysed including all individuals, with adjustment (0, 1) for treatment of type 2 diabetes, hypertension, dyslipidaemia or CHD (‘all participants’).

Results

Characteristics of participants

Characteristics of participants are summarised in Table 1. Among all participants, median age was 39.4 years with 52% male; overall 22% had CHD, type 2 diabetes or were on treatment for hypertension or dyslipidaemia.
Table 1

Phenotypic characteristics of participants after removing outliers

Characteristic

All

No drug therapya

nb

Value

nb

Value

Age (years)

1,634

39.4 (25.9–50.5)

Sex (male) (%)

1,634

52

  

CHD (%)

1,634

16

Hypertension on treatment (%)

1,634

16

SBP (mmHg)

1,622

121 (110–133)

1,248

119 (109–129)

DBP (mmHg)

1,622

77 (69–83)

1,248

74 (68–81)

BMI (kg/m2)

1,624

25.8 (22.9–28.7)

WHR

1,623

0.87 (0.79–0.94)

Lipid-lowering treatment (%)

1,634

8

TG (mmol/l)

1,600

1.32 (0.92–1.91)

1,338

1.23 (0.88–1.82)

HDL-cholesterol (mmol/l)

1,601

1.22 (1.04–1.48)

1,339

1.25 (1.07–1.50)

Type 2 diabetes on treatment (%)

1,634

9

Glucose (mmol/l)

1,555

5.1 (4.7–5.5)

1,457

5.1 (4.7–5.4)

HbA1c (%)

1,107

4.9 (4.6–5.2)

1,019

4.8 (4.6–5.1)

HOMA-IR

1,538

1.9 (1.2–3.2)

1,404

1.8 (1.2–2.8)

Data are presented as median (inter-quartile range) or %

aObservations for individuals not on BP-, lipid- or glucose-lowering drug therapy

bNumber of observations

Phenotype information was available for 1,634 of the 2,188 relatives in the families included. On average, there were 12 people (range 3–48), and three generations (range 2–5) per family. A summary of the number of relative pairs for full pedigrees and the phenotyped subsets is in ESM Table 2.

Heritabilities and genetic correlations

Table 2 presents heritabilities and common environmental effects for the untreated group, and for all participants. All heritability estimates were statistically significant except for loge glucose in the treated group. Heritability estimates (SE) for the untreated group were: BMI 0.31 (0.04), WHR 0.27 (0.04), SBP 0.29 (0.03), TG 0.40 (0.04), HDL-cholesterol 0.53 (0.04), glucose 0.37 (0.03), HOMA-IR 0.22 (0.04) and HbA1c 0.60 (0.04). Heritability estimates were lower for all phenotypes when analysed among all participants. Common environmental effects were low for all traits, and for the untreated group were only significant for SBP, BMI and loge HOMA-IR.
Table 2

Ratios of the estimated variance components for all eight traits from all participants and the untreated group

Phenotype

Untreated group

All participantsb

Heritabilities, h2 (SE)

Common environment, c2 (SE)

Heritabilities, h2 (SE)

Common environment, c2 (SE)

SBP

0.29 (0.03)**

0.11 (0.03)**

0.18 (0.03)**

0.12 (0.02)**

BMI

0.31 (0.04)**

0.13 (0.03)**

0.30 (0.03)**

0.13 (0.02)**

WHR

0.27 (0.04)**

0.04 (0.02)

0.24 (0.03)**

0.09 (0.02)**

Loge glucose

0.37 (0.03)**

0.04 (0.02)

0.07 (0.03)

0.07 (0.02)*

Loge HDL-C

0.53 (0.04)**

0.03 (0.02)

0.45 (0.03)**

0.05 (0.01)**

Loge TG

0.40 (0.04)**

0.07 (0.04)

0.09 (0.02)**

0.03 (0.01)

HbA1c

0.60 (0.04)**

0.03 (0.02)

0.16 (0.03)**

0.15 (0.04)**

Loge HOMA-IR

0.22 (0.04)**

0.10 (0.03)*

0.19 (0.03)**

0.09 (0.02)**

aUntreated group: individuals with type 2 diabetes, CHD, hypertension and lipid-lowering drugs excluded

bAll participants: all individuals included, with adjustment for treatment effects

*p < 0.01, **p < 0.001, Wald test

HDL-C, HDL-cholesterol

Genetic correlations are shown in Table 3. In the untreated group, a correlation >|0.5| was found between BMI and loge HOMA-IR, and correlations >|0.3| were found for: WHR and both SBP and BMI; loge HOMA-IR and loge glucose; and between loge HDL-cholesterol and each of loge TG and HbA1c. All these, and several correlations of smaller magnitude, were statistically significant.
Table 3

Genetic correlations between the traits from all participants and the untreated group

Phenotype

BMI

WHR

Loge glucose

Loge HDL-cholesterol

Loge TG

HbA1c

Loge HOMA-IR

Untreated groupa

SBP

0.01 (0.09)

0.32 (0.09)**

−0.16 (0.09)

0.01 (0.07)

0.16 (0.08)

0.11 (0.07)

−0.18 (0.12)

BMI

 

0.44 (0.06)**

0.09 (0.07)

0.09 (0.07)

0.05 (0.08)

0.25 (0.05)**

0.57 (0.07)**

WHR

  

−0.22 (0.10)

0.02 (0.08)

0.27 (0.09)*

0.28 (0.06)**

0.24 (0.09)*

Loge glucose

   

−0.28 (0.05)**

0.01 (0.06)

0.19 (0.06)**

0.35 (0.07)**

Loge HDL-cholesterol

    

−0.34 (0.06)**

−0.38 (0.07)**

−0.13 (0.09)

Loge TG

     

0.25 (0.06)

0.18 (0.10)

HbA1c

      

0.16 (0.07)

All participantsb

SBP

0.12 (0.07)

0.34 (0.07)**

−0.09 (0.13)

−0.01 (0.05)

0.12 (0.14)

0.06 (0.10)

−0.15 (0.08)

BMI

 

0.56 (0.06)**

0.08 (0.13)

0.15 (0.06)

−0.10 (0.10)

0.10 (0.09)

0.54 (0.09)**

WHR

  

−0.11 (0.15)

−0.04 (0.05)

0.40 (0.17)

0.39 (0.08)**

0.23 (0.09)*

Loge glucose

   

−0.07 (0.09)

0.22 (0.16)

−0.15 (0.16)

0.32 (0.11)*

Loge HDL-cholesterol

    

−0.50 (0.11)**

−0.41 (0.08)**

−0.19 (0.07)*

Loge TG

     

0.15 (0.23)

−0.12 (0.14)

HbA1c

      

−0.30 (0.18)

Values are rA (SE)

aUntreated group: individuals with type 2 diabetes, CHD, hypertension and lipid-lowering drugs excluded

bAll participants: all individuals included, with adjustment for treatment effects

*p < 0.01, **p < 0.001, Wald test

Discussion

Family and twin studies indicate that IR, and its related metabolic phenotypes are heritable in Europeans and other populations (ESM Tables 3 and 4). Ours is the first large-scale study showing that IR and component phenotypes are highly heritable amongst Asian Indians. Our findings are consistent with the view that genetic factors contribute to the high prevalence of IR and related metabolic disturbances in this population.

The heritabilities reported here provide strong support for efforts to discover new genetic loci underlying IR and related metabolic disturbances in Asian Indians. Heritabilities refer to a particular population, hence comparison of estimates across populations is not straightforward, as implied by the wide range of estimates (ESM Tables 3 and 4). However, in this study, we found a significant contribution of genetic factors for this population, especially for HDL-cholesterol, TG and HbA1c.

It has been suggested that genes influencing IR have pleiotropic effects on metabolic syndrome-related traits. We found moderate and high genetic correlations between BMI, WHR and impaired HOMA-IR. This implies that genes underlying an increase in general and central adiposity may also influence IR in this population. Support for this view comes from recent studies that show that variants near the MC4R gene are associated with both central adiposity and IR in Asian Indians [7].

Like other studies of heritability, our study has limitations. Heritability estimates reflect the ratio of genetic and total variance, and can therefore be influenced by population variance, disease and treatment effects. We therefore estimated heritability both with and without participants on treatment for diabetes, hypertension, raised lipids or CHD; estimates were consistently higher without these participants. Our use of a multivariate model to analyse all traits simultaneously allows more precise estimation, and taking a shared environment into account should avoid an upward bias that can affect studies ignoring these effects.

In conclusion, our findings of moderate and high heritabilities for, and significant genetic correlations between, IR component phenotypes in Asian Indian CHD families suggest that genetic effects contribute substantially to IR in this population. Our results support the view that common genetic mechanisms underlie IR and related metabolic disturbances amongst Asian Indians.

Acknowledgements

The authors would like to thank all the members of the families that participated in the study. D. Zabaneh is funded by the British Heart Foundation. Part of this work appeared as an abstract in the 16th Annual Meeting of the International Genetic Epidemiology Society 31:651-651 (September 2007).

Duality of interest

The authors declare that there is no duality of interest associated with this manuscript

Supplementary material

125_2009_1504_MOESM1_ESM.pdf (15 kb)
ESM Table 1Characteristics of traits for Sikhs and Hindus (PDF 15.2 kb)
125_2009_1504_MOESM2_ESM.pdf (10 kb)
ESM Table S2Numbers of individuals and relative pairs included in the analyses (PDF 10.1 kb)
125_2009_1504_MOESM3_ESM.pdf (30 kb)
ESM Table S3Heritabilities of metabolic traits from different studies and populations (PDF 29 kb)
125_2009_1504_MOESM4_ESM.pdf (21 kb)
ESM Table S4Summary of studies (PDF 21 kb)
125_2009_1504_MOESM5_ESM.pdf (21 kb)
(PDF 20.8 kb)

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  1. 1.Department of Epidemiology and Public HealthImperial College LondonLondonUK
  2. 2.National Heart and Lung Institute, Imperial College LondonHammersmith Hospital CampusLondonUK
  3. 3.National Heart and Lung Institute, Imperial College LondonSouth Kensington CampusLondonUK
  4. 4.UCL Genetics Institute (UGI), Kathleen Lonsdale BuildingUniversity College LondonLondonUK

Personalised recommendations